Anna Decker

Anna Decker is a data scientist with over a decade of experience. Her research focuses on causal inference and developing machine learning methods for healthcare and bioinformatics applications. In her current role at Moderna, Anna leads algorithmic development for individualized neoantigen therapies. She also serves as a board member of the City of Cambridge Open Data Review Board.